BlackRock Fund Advisors - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 29 filers reported holding CASI PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$44,000
+10.0%
37,886
+5.4%
0.00%
Q3 2016$40,000
-4.8%
35,958
+0.8%
0.00%
Q2 2016$42,000
+10.5%
35,663
-1.1%
0.00%
Q1 2016$38,000
+2.7%
36,049
-5.6%
0.00%
Q4 2015$37,0000.0%38,205
+9.2%
0.00%
Q3 2015$37,000
-42.2%
34,982
-2.6%
0.00%
Q2 2015$64,000
+36.2%
35,906
+13.7%
0.00%
Q1 2015$47,000
+4.4%
31,578
-6.4%
0.00%
Q4 2014$45,000
-19.6%
33,722
+7.7%
0.00%
Q3 2014$56,00031,3100.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders